"Designing Growth Strategies is in our DNA"
Fertility testing devices are used to track menstrual cycle, ovulation days, fertile window and other important aspects of sexual life. Certain factors such as sperm count, sperm motility, structure of sperm, total semen volume and others are considered to be a prominent aspects while evaluating the male fertility using fertility testing devices. In 2018, according to data analyzed by the Indian Society of Assisted Reproduction, an estimated 14.0% population suffer from infertility each year in India. Combined with these trends, factos such as excessive consumption of alcohol, smoking, and stress due to gradual shift of mentality towards profession oriented lifestyle, are certain risk factors that are responsible to affect the sexual health of general population.
Key Market Driver -
Introduction of technologically advance devices
Key Market Restraint -
Less awareness about fertility test among rural areas
In 2018, according to the Centres for Disease Control and Prevention (CDC), an estimated 10% of women had difficulty in maintaining their pregnancy in the U.S. These statistics along with other factors such as lifestyle changes, and increasing prevalence of infertility in both males and females are anticipated to drive the fertility testing devices market growth. The demand for fertility testing devices is further augmented by the introduction of technologically advanced devices, and entry of domestic players fertility testing devices market.
However low adoption and awareness of fertility testing devices in emerging countries, along with social stigma among general population, are some factors restraining the fertility testing devices market growth.
The major companies in the global fertility testing devices market report include HILIN LIFE PRODUCTS, Church & Dwight Co., Inc., Abbott, Prestige Consumer Healthcare, Inc., TaiDoc Technology Corporation, bioZhena Corporation, Quidel Corporation and other key players.
The global fertility testing devices market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America and Europe are projected to dominate the global fertility testing during the forecast period owing to factors such as increasing awareness among general population towards infertility, and increasing prevalence of infertility in both the genders. Asia Pacific is projected to register a higher CAGR in the forecast period due to rising awareness about family planning and prevalent infertility among men and women.
To gain extensive insights into the market, Request for Customization
In 2018, according to the Indian Society of Assisted Reproduction, infertility affected to about 10 to 14 percent of the Indian population, with higher rates in urban areas where one out of six couples were affected. These trends are anticipated to increase the demand of fertility testing devices and drive the market growth at faster pace in Asia Pacific. Latin America and Middle East Africa is expected to register a comparatively higher CAGR by the end of 2026.
ATTRIBUTE | DETAILS |
By Product |
|
By Gender |
|
By Distribution Channel |
|
By Geography |
|
US +1 833 909 2966 ( Toll Free )